LENZ Therapeutics | SC 13G:超过5%持股股东披露文件-Ridgeback Capital Investments L.P.(7.2%),Ridgeback Capital Investments LLC(7.2%)等
LENZ Therapeutics | 4:持股变动声明-高管 Schimmelpennink Evert B.
Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Therapeutics | 4:持股变动声明-董事 MCCOLLUM JAMES W
Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(4.8%),Oleg Nodelman(4.8%)等
Therapeutics | SC 13D:超过5%持股股东披露文件-RA Capital Management, L.P.(16.6%),Peter Kolchinsky(16.6%)等
Therapeutics | 3:首次持股声明-股东 Alpha Wave Ventures GP, Ltd
Therapeutics | SC 13G:超过5%持股股东披露文件-Alpha Wave Global, LP(14.1%),Alpha Wave Ventures GP, Ltd(14.1%)等
Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Therapeutics | 3:首次持股声明-董事 RA CAPITAL MANAGEMENT, L.P.
Therapeutics | 4:持股变动声明-董事 Thunen Shelley B
Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Dr. Srinivas Akkaraju(4.8%),Samsara BioCapital, L.P.(4.7%)等
Therapeutics | 4:持股变动声明-董事 MCCOLLUM JAMES W
Therapeutics | 4:持股变动声明-董事 Guerard Frederic
Therapeutics | 4:持股变动声明-董事 Scheiner Zachary
Therapeutics | 4:持股变动声明-董事 Drapkin Kimberlee C
Therapeutics | 3:首次持股声明-董事 Scheiner Zachary
Therapeutics | 4:持股变动声明-董事 George Jeffrey P.
Therapeutics | 4:持股变动声明-高管 Chevallard Daniel R.
Therapeutics | 4:持股变动声明-高管 Olsson Shawn
暂无数据
暂无数据